Click image to enlarge
The
U-PLEX platform offers validated components that can be combined to create high quality assays quickly and easily. The U-PLEX Human IL-13 Antibody Set is a matched pair of antibodies that can be used (with other U-PLEX components such as plates, calibrators, diluents, and MSD GOLD Read Buffer B) to build U-PLEX assays that measure IL-13. These assays can measure IL-13 alone or in multiplex panels with other biomarkers. The Product Inserts in the “Documentation” tab (below) provide detailed instructions for building assays with U-PLEX Antibody Sets.
For information on multiplexing IL-13 with other analytes, please see
U-PLEX Biomarker Group 1 (hu) Assays,
U-PLEX Metabolic Group 1 (hu) Assays, or
U-PLEX Immuno-Oncology Group 1 (hu) Assays.
-
Specifications
-
-
Kit Contents
-
Documentation
-
References
Analyte(s)
|
|
IL-13
|
|
Species
|
|
Human
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
2-8 °C
|
|
Gene ID(s)
|
|
3596
|
|
UniProt ID(s)
|
|
P35225
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Biotin Human IL-13 Antibody, 1 Plate Size
|
2-8 °C
|
1 vial (1 plate size)
|
|
SULFO-TAG Human IL-13 Antibody, 1 Plate Size
|
2-8 °C
|
1 vial (1 plate size)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Biotin Human IL-13 Antibody, 5 Plate Size
|
2-8 °C
|
1 vial (5 plate size)
|
|
SULFO-TAG Human IL-13 Antibody, 5 Plate Size
|
2-8 °C
|
1 vial (5 plate size)
|
|
Product Inserts
|
|
|
Datasheets
|
|
|
Product Highlights
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics
|
|
|
|
Early and late effects of maternal experience on hippocampal neurogenesis, microglia, and the circulating cytokine milieu
|
|
|
|
Cytokine biomarkers in tear film for primary open-angle glaucoma
|
|
|
|
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling.
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters